Oncology News | pharmaphorum

News

Oracle co-founder Larry Ellison leads $21.5m round for Image...

Israeli cancer diagnosis start-up Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform-based digitised imaging of biopsy samples.

News

Gilead dives deeper into NK cell therapies with Dragonfly de...

Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cance

News

FDA says no to two more China-developed cancer drugs

The FDA has declined to approve two more cancer therapies developed by drugmakers based in China, in what may be further evidence of a tough line taken by the regulator for drugs tested out

News

Smartphone-based skin cancer diagnostic certified for use in...

An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been cleared in the UK as a Class IIA medical device, setting up broader use of t

News

Enhertu gets breakthrough tag in HER2-low breast cancer

AstraZeneca and Daiichi Sankyo have claimed a fifth breakthrough designation from the FDA for Enhertu, shortly after showing the drug extended survival in patients with HER2-low metastatic

News

After bempeg failure, Nektar wields the axe

Nektar has said it will cut 70% of its workforce in the wake of the comprehensive failure in trials of its immuno-oncology candidate bempegaldesleukin, which was discontinued last week.

Oracle co-founder Larry Ellison leads $21.5m round for Image...

Gilead dives deeper into NK cell therapies with Dragonfly de...

FDA says no to two more China-developed cancer drugs

Smartphone-based skin cancer diagnostic certified for use in...

Enhertu gets breakthrough tag in HER2-low breast cancer

After bempeg failure, Nektar wields the axe

Vanda ends 40-year hiatus for new motion sickness drugs

How to meet your physicians where they are online

News

Editor's Picks